Cipla - Quaterly Results

27 Oct 2023 Evaluate
The revenue zoomed 12.37% to Rs. 46647.20 millions for the quarter ended September 2023 as compared to Rs. 41512.70 millions during the corresponding quarter last year.A good growth in profit of 46.02% reported to Rs. 10296.90  millions over Rs. 7051.90 millions of corresponding previous quarter.Operating profit for the quarter ended September 2023 rose to 15842.10 millions as compared to 11533.30 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 46647.20 41512.70 12.37 89829.10 79974.10 12.32 157906.00 153808.20 2.66
Other Income 2050.90 922.80 122.25 3630.70 2099.60 72.92 4567.90 6667.00 -31.48
PBIDT 15842.10 11533.30 37.36 29468.80 22646.50 30.13 42493.70 43779.30 -2.94
Interest 78.00 75.00 4.00 81.10 97.10 -16.48 270.20 269.30 0.33
PBDT 15764.10 11458.30 37.58 29387.70 22549.40 30.33 40364.50 43510.00 -7.23
Depreciation 1798.10 1760.10 2.16 3157.60 3043.70 3.74 5959.10 5466.20 9.02
PBT 13966.00 9698.20 44.01 26230.10 19505.70 34.47 34405.40 38043.80 -9.56
TAX 3669.10 2646.30 38.65 6983.00 5150.50 35.58 9710.10 9218.00 5.34
Deferred Tax -13.00 -6.00 116.67 -102.50 -95.30 7.56 -400.90 -276.90 44.78
PAT 10296.90 7051.90 46.02 19247.10 14355.20 34.08 24695.30 28825.80 -14.33
Equity 1614.70 1614.00 0.04 1614.70 1614.00 0.04 1614.30 1613.60 0.04
PBIDTM(%) 33.96 27.78 22.24 32.81 28.32 15.85 26.91 28.46 -5.46

Cipla Share Price

1388.00 0.00 (0.00%)
07-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.15
Dr. Reddys Lab 6277.10
Cipla 1388.00
Zydus Lifesciences 980.65
Lupin 1610.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.